Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

378

Participants

Timeline

Start Date

January 11, 2021

Primary Completion Date

March 17, 2022

Study Completion Date

March 17, 2022

Conditions
Ocular Inflammation and Pain
Interventions
DRUG

APP13007, 0.05%

APP13007 eye drop, 0.05%

DRUG

Matching Vehicle Placebo for APP13007, 0.05%

Matching vehicle placebo eye drop

Trial Locations (35)

10013

Raymond Fong, MD, PC, New York

18702

Bucci Laser Vision Institute, Wilkes-Barre

28387

Carolina Eye Associates, Southern Pines

30076

Coastal Research Associates, LLC, Roswell

32174

International Eye Associates, PA, Ormond Beach

32204

Levenson Eye Associates, Jacksonville

33870

Newsom Eye and Laser Center, Sebring

40220

Senior Health Services, Louisville

43215

Eye Physicians, LLC, Columbus

46290

Midwest Cornea Associates, LLC, Carmel

60046

Jacksoneye SC, Columbus

63090

Comprehensive Eye Care, Ltd., Washington

63131

Ophthalmology Consultants, Ltd., St Louis

64133

Silverstein Eye Centers, PC, Kansas City

77008

Houston Eye Associates, Houston

77034

Advanced Laser Vision and Surgical Institute, Houston

78229

R and R Eye Research, LLC, San Antonio

78238

San Antonio Eye Center, San Antonio

78731

Keystone Research Ltd., Austin

78738

Lake Travis Eye and Laser Center, Lakeway

78750

Retina Research Center, PLLC, Austin

81501

Icon Eye Care, Grand Junction

84117

Stacy R. Smith, MD, PC, Salt Lake City

85260

Schwartz Laser Eye Center, Scottsdale

89052

NV Eye Surgery, Henderson

89145

Center For Sight, Las Vegas

90805

SoCal Eye Physicians and Associates, Long Beach

91204

Global Research Management, Glendale

91345

North Valley Eye Medical Group, Inc., Mission Hills

92056

Pendleton Eye Center, Oceanside

92545

Inland Eye Specialists, Hemet

92562

LoBue Laser and Eye Medical Center, Inc., Murrieta

95670

Martel Eye Medical Group, Rancho Cordova

96001

Shasta Eye Medical Group, Inc., Redding

00921

Centro Oftalmologico Metropolitano, San Juan

Sponsors
All Listed Sponsors
lead

Formosa Pharmaceuticals, Inc.

INDUSTRY